Lisata Therapeutics, Inc. Common Stock
Symbol: LSTA (NASDAQ)
0.00
▼ (-100.00%) -2.350
Company Description:
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $2.35
- Yesterday High: $2.43
- Yesterday Low: $2.34
- Yesterday Volume: 34.74K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Lisata Therapeutics, Inc. Common Stock
- Website: https://www.lisata.com
- Listed Date: 1999-03-01
- Location: BASKING RIDGE, NJ
- Market Status: Active
- CIK Number: 0000320017
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $21.01M
- Round Lot: 100
- Outstanding Shares: 8.76M
- Asset Type: CS
RECENT FILINGS FOR LSTA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-14 | 8-K | View |
| 2025-10-08 | 8-K | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-15 | 8-K | View |
| 2025-06-26 | 8-K | View |
| 2025-06-17 | 8-K | View |
| 2025-06-13 | 8-K | View |
| 2025-06-10 | 8-K | View |
| 2025-05-08 | 10-Q | View |
| 2025-05-08 | 8-K | View |
| 2025-04-25 | DEFA14A | View |
| 2025-04-25 | DEF 14A | View |
| 2025-02-27 | 10-K | View |
| 2025-02-27 | 8-K | View |
| 2025-02-05 | 3 | View |
| 2025-01-23 | 8-K | View |
| 2025-01-13 | 4 | View |
| 2025-01-13 | 4 | View |
| 2025-01-13 | 4 | View |
Latest News on LSTA